Evidence map›Paper›PMID 42220376›Full record

ArticleFrontiers in psychology2026

Psychometric validation of the Cannabis Withdrawal Checklist in a Spanish sample with cannabis use disorder.

Judith Saura, Ariadna Feliu, Marta Enríquez, Xavier Roca, Montse Ballbè, Marcela Fu, Lidia Segura, Esteve Fernández, Cristina Martínez

Abstract read
In one paragraph

Article in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Judith SauraTobacco Control Unit, Cancer Control and Prevention Program, WHO Collaborating Center on Tobacco Control, Institut Català d'Oncologia - ICO, l'Hospitalet de Llobregat, Barcelona, Spain.
Ariadna FeliuCIBER en Enfermedades Respiratorias - CIBERES, Instituto de Salud Carlos III, Madrid, Spain.
Marta EnríquezTobacco Control Unit, Cancer Control and Prevention Program, WHO Collaborating Center on Tobacco Control, Institut Català d'Oncologia - ICO, l'Hospitalet de Llobregat, Barcelona, Spain.
Xavier RocaAddictive Behaviors Unit, Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Montse BallbèTobacco Control Unit, Cancer Control and Prevention Program, WHO Collaborating Center on Tobacco Control, Institut Català d'Oncologia - ICO, l'Hospitalet de Llobregat, Barcelona, Spain.
Marcela FuTobacco Control Unit, Cancer Control and Prevention Program, WHO Collaborating Center on Tobacco Control, Institut Català d'Oncologia - ICO, l'Hospitalet de Llobregat, Barcelona, Spain.
Lidia SeguraSecretariat of Public Health, Department of Health, Generalitat de Catalunya, Barcelona, Spain.
Esteve FernándezTobacco Control Unit, Cancer Control and Prevention Program, WHO Collaborating Center on Tobacco Control, Institut Català d'Oncologia - ICO, l'Hospitalet de Llobregat, Barcelona, Spain.
Cristina MartínezTobacco Control Unit, Cancer Control and Prevention Program, WHO Collaborating Center on Tobacco Control, Institut Català d'Oncologia - ICO, l'Hospitalet de Llobregat, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Cannabis is used globally. In Spain, it is often used in combination with tobacco, which may exacerbate withdrawal severity. Currently, no validated instrument exists to assess cannabis withdrawal symptoms in Spanish populations. This study aimed to validate the 15-item Cannabis (Marijuana) Withdrawal Checklist (CWC) for Spanish-speaking individuals who co-use cannabis and tobacco. Materials and methods: This psychometric validation study was nested within a multicenter longitudinal project conducted across 10 substance use treatment programs in Catalonia (Spain). The CWC was forward- and back-translated following COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) recommendations. Internal consistency, construct validity, and sensitivity to change over time were assessed using Cronbach's alpha, exploratory factor analysis (EFA), and mixed-effects analysis. Data from 82 participants were used to conduct the validation. Results: The adapted CWC demonstrated high internal consistency (Cronbach's Conclusion: The Spanish CWC showed strong reliability and acceptable psychometric properties, supporting its use for assessing cannabis withdrawal symptoms in Spanish-speaking adults, particularly those who co-use tobacco products. The scale may be valuable in both research and clinical settings, particularly for monitoring withdrawal during treatment interventions. Further validation using larger, more diverse samples is warranted. Clinical trial registration: Clinicaltrials.gov, identifier NCT0551209.

Indexed as

cannabis-tobacco co-useCannabis withdrawalpsychometric assessmentscale validationsubstance use disorders

Identifiers

PMID42220376
PMCPMC13219039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.